Early COVID-19 drug trial halted after just 8 patients

NCT ID NCT04333654

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times

Summary

This study aimed to see if hydroxychloroquine could reduce the amount of virus in the nose and throat of adults with mild COVID-19. Only 8 people took part before the study was stopped early. The trial compared the drug to a placebo (a dummy pill) and looked at safety and symptom changes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONAVIRUS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigational Site Number 0561001

    Brussels, BE-1200, Belgium

  • Investigational Site Number 0561002

    Lodelinsart, 6042, Belgium

  • Investigational Site Number 2501001

    Bordeaux, 33076, France

  • Investigational Site Number 2501002

    Paris, 75005, France

  • Investigational Site Number 5281001

    Groningen, 9728 NZ, Netherlands

  • Investigational Site Number 5281002

    Harderwijk, 3844 DG, Netherlands

  • Investigational Site Number 8400001

    Boston, Massachusetts, 02115, United States

Conditions

Explore the condition pages connected to this study.